Article
Rosiglitazone alleviates Parkinson's disease phenotypes of Drosophila via dCTP-mediated inhibition of AGE-RAGE pathway.
Neuropharmacology - 1 Oct 2026
Kang Yubing, Yang Yan, Wang Zumeng, Chang Yumin, Wang Ning, Yang Jing, Lim Kahleong, Yu Fengwei, Wang Mingyu, Lu Li, Zhang Chengwu
Abstract excerpt
BACKGROUND: Parkinson's disease (PD) is an aging-related neurodegenerative disorder, which threatens the health and life of millions of patients worldwide, but remains incurable. Developing novel interventive strategy is urgent yet unmet. In recent years, it was well accepted that pathogenesis of PD closely correlated with aberrant glucolipid metabolism. The antidiabetic drug, Rosiglitazone (Rosi), one typical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
